HAPTOGLOBIN FOR USE IN TREATING OR PREVENTING EXAGGERATED ERECTILE RESPONSE OR ERECTILE… Application WO-2024047219-A1 World Intellectual Property Organisation (WIPO) 07 Mar 2024
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imi… Grant US-11883383-B2 United States of America 30 Jan 2024
Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-pr… Grant US-11524942-B2 United States of America 13 Dec 2022
Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phe… Grant US-11420942-B2 United States of America 23 Aug 2022